Οξεία Μυελογενή Λευχαιμία

Good News

3 Greeks behind the discovery of a novel, groundbreaking function of leukaemia cells

Kostas
A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that could open new avenues to develop effective treatments against this potentially lethal disease. Researchers from the Wellcome Trust Sanger Institute, the Gurdon Institute and their collaborators show that inhibiting the METTL3...
Achievements

In search for novel biological pathways and therapies for AML

Kostas
Konstantinos Tzelepis is a Phd student at the Wellcome Trust Sanger Institute in Unicersity of Cambridge. He was born and raised in Peiraias, Greece. He studied Biomedical Sciences at TEI Athens and Human Neoplastic Disease (Cancer studies) in the Medical School of Athens. After his studies...

Αυτός ο ιστότοπος χρησιμοποιεί cookies για να βελτιώσει την εμπειρία σας. Θα υποθέσουμε ότι είστε εντάξει με αυτό, αλλά μπορείτε να εξαιρεθείτε εάν το επιθυμείτε. ΑΠΟΔΟΧΗ Περισσότερα